M&A Activity • Jan 7, 2020
M&A Activity
Open in ViewerOpens in native device viewer
7 January 2020 – before opening of markets Under embargo until 08:30 CET
Public limited liability company Public regulated real estate company under Belgian law Registered office: Rue Belliard 40 (box 11), 1040 Brussels Enterprise number: 0877.248.501 (RLE Brussels) (the 'Company')
In November 2019, Aedifica launched a voluntary public tender offer on all shares of Hoivatilat through its Finnish subsidiary Aureit Holding Oy1 for which the offer period ended on 3 January 2020.
According to the preliminary result of the tender offer, approx. 90.0% of all issued and outstanding shares and votes in Hoivatilat have been validly tendered during the offer period.
Taking into account this preliminary result and the number of shares that Aedifica acquired from public trading on Nasdaq Helsinki until January 3 representing 5.5% of all issued and outstanding shares and votes in Hoivatilat, Aedifica has now control over approx. 95.5% of all issued and outstanding shares and votes in Hoivatilat.
The final result of the tender offer will be confirmed and announced on 9 January 2020 and completion and settlement of the offer will be on 10 January 2020. In connection with the announcement of the final result, and provided that the tender offer will be completed, Aedifica will announce whether a subsequent offer period will commence in accordance with the terms and conditions of the tender offer and whether squeeze-out proceedings will be started.
Stefaan Gielens, CEO of Aedifica, commented: "Aedifica is delighted with the preliminary result of the tender offer and welcomes Hoivatilat within the Aedifica group. Hoivatilat and its team show a great track record of value creation in the Nordics and we believe that, next to opening the Nordics healthcare real estate markets for Aedifica, Hoivatilat's build-and-hold model will add a new dimension to Aedifica's growth story."
1 See press releases of 4 November 2019, 27 November 2019 and 5 December 2019.
Aedifica is a Regulated Real Estate Company under Belgian law specialised in European healthcare real estate, particularly in senior housing. Aedifica has developed a portfolio of more than 270 sites in Belgium, Germany, the Netherlands and the United Kingdom, worth more than €2.4 billion.
In November 2019, the Group launched a tender offer on the shares of Hoivatilat, the Finnish healthcare real estate investor with which Aedifica wants to enter the Nordics.
Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following ticker symbols: AED; AED:BB (Bloomberg); AOO.BR (Reuters).
The Company's market capitalisation was approx. €2.8 billion as of 6 January 2020.
Aedifica is included in the EPRA and Stoxx Europe 600 indices.
This document contains forward-looking information that involves risks and uncertainties, including statements about Aedifica's plans, objectives, expectations and intentions. Readers are cautioned that forward-looking statements include known and unknown risks and are subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond the control of Aedifica. Should one or more of these risks, uncertainties or contingencies materialise, or should any underlying assumptions prove incorrect, actual results could vary materially from those anticipated, expected, estimated or projected. As a result, Aedifica does not assume any responsibility for the accuracy of these forward-looking statements.
Chief Financial Officer
T +32 2 626 07 73 [email protected] Delphine Noirhomme Investor Relations Manager
T +32 2 210 44 98 [email protected]
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.